26
|
Daniels P, Shilian R, Huq M, Hostoffer R. Eosinophilic fasciitis in common variable immunodeficiency with hypereosinophilia. Ann Allergy Asthma Immunol 2020; 126:99-100. [PMID: 32891788 DOI: 10.1016/j.anai.2020.08.395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Revised: 08/09/2020] [Accepted: 08/31/2020] [Indexed: 10/23/2022]
|
27
|
Fill L, Hadney L, Graven K, Persaud R, Hostoffer R. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019. Ann Allergy Asthma Immunol 2020; 125:112-114. [PMID: 32387167 PMCID: PMC7199724 DOI: 10.1016/j.anai.2020.04.033] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2020] [Revised: 04/28/2020] [Accepted: 04/30/2020] [Indexed: 01/08/2023]
|
28
|
Sanan N, Schend J, Rowane M, Hostoffer R. Expedited Desensitization to Canakinumab. ALLERGY & RHINOLOGY 2020; 11:2152656720937694. [PMID: 32612876 PMCID: PMC7309336 DOI: 10.1177/2152656720937694] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Introduction Interleukin-1 (IL-1) antagonists have been successful in the management of monogenic auto-inflammatory diseases, notably classic hereditary fever syndromes, such as Familial Mediterranean Fever (FMF). Anakinra (Kineret®), a human recombinant IL-1 receptor antagonist (IL-1Ra), has been clinically effective in the management of persistent auto-inflammation, such as FMF. Few studies report anaphylaxis in response to anakinra, which were resolved with an anakinra desensitization or the anti-IL-1β monoclonal antibody canakinumab (ILARIS®). We describe the first reported desensitization protocol to canakinumab. Case Report A 51-year-old man with a prior history of FMF presented with history of failed colchicine, nonsteroidal anti-inflammatory drug, and anakinra trials. Anakinra desensitization and canakinumab intradermal testing (IDT) resulted in anaphylactic and allergic symptoms, respectively. Expedited desensitization to canakinumab was successfully performed with 15-minute intervals between 13 doses of incremental increase to 150 mg. Discussion Biological agents are immune modulators that may evoke unanticipated hypersensitivity reactions, including anaphylaxis. These anaphylactic reactions to biologics have been infrequently reported, but the expanding market may increase the risk of IgE-mediated hypersensitivities and subsequent need for desensitization protocols. The current, expedited desensitization evaluated several published protocols involving anakinra desensitization to determine appropriate dosing for canakinumab. Conclusion We report the gastrointestinal intolerance and continued FMF flares on colchicine, followed by anaphylactic responses to anakinra and allergic reaction to IDT of canakinumab, in the present case of FMF. Our novel, expedited canakinumab desensitization protocol serves as an effective and alternative therapy in cases when other appropriate biologic agents are not tolerated.
Collapse
|
29
|
Jeskey J, Parida A, Graven K, Hostoffer R. Novel Gene Deletion in NLRC4 Expanding the Familial Cold Inflammatory Syndrome Phenotype. ALLERGY & RHINOLOGY 2020; 11:2152656720928062. [PMID: 32537258 PMCID: PMC7268108 DOI: 10.1177/2152656720928062] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Familial cold inflammatory syndrome (FCAS) is a rare, inherited inflammatory disease characterized by episodes of fever, rash, and arthralgias after exposure to cold stimuli. Previous literature has established FCAS linked to autosomal dominant mutations in the NLRP3 (CIAS1) and NLRP12 genes. Moreover, there has been recent evidence of NLRC4-inflammasomopathies. Although there have been cases of FCAS secondary to missense mutations in NLRC4, we report the first symptomatic case associated with a 93-base-pair in-frame deletion within Exon 5 of the leucine rich repeat domain.
Collapse
|
30
|
Rowane M, Valencia R, Schend J, Jhaveri D, Hostoffer R. Something to Sweat About: Two Cases of Dupilumab-Induced Hyperhidrosis and Bromhidrosis. ALLERGY & RHINOLOGY 2020; 11:2152656720927703. [PMID: 32489715 PMCID: PMC7241203 DOI: 10.1177/2152656720927703] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Introduction Atopic dermatitis (AD, eczema) is familial chronic inflammatory skin disease of complex etiology and increasing prevalence. Dupilumab is an IL-4 receptor subunit alpha (IL-4Rα) antagonist that is the first Food and Drug Administration-approved biological therapy for moderate-to-severe adult AD inadequately controlled with topical therapies. Adverse effects reported in the literature include injection site reactions, conjunctivitis, headache, and nasopharyngitis. Objective We report the first cases of hyperhidrosis and bromhidrosis as side effects from dupilumab (Dupixent®) for the treatment of AD. Case Reports Case 1 is a 20-year-old woman with controlled allergic rhinitis and severe AD reported axillary hyperhidrosis with bromhidrosis, comparable to sweat from high-intensity exercise, with no relief from several different over-the-counter antiperspirants. Case 2 is a 61-year-old woman with history of chronic asthma, allergic contact dermatitis, allergic rhinitis, and AD noticed markedly increased sweating with bromhidrosis that was reminiscent of her menopausal symptomology, about 3 months after initiating dupilimab. Discussion Traditional immunosuppressive agents and corticosteroids have limited efficacy, numerous side effects, and increased risk of infection. The safety profile and efficacy of the newly approved IL-4Rα antagonist dupilumab may be favorable to oral immunosuppressants, but its use remains limited to severe recalcitrant cases, due to financial implications and lack of long-term safety data and comparative head-to-head trials. Conclusion We report improved outcomes with dupilumab, in addition to unpublished cases of bromhidrosis and hyperhidrosis in 2 patients with AD. This report of additional complications may inspire further clinical research and assist clinicians in considering the option of dupilumab for uncontrolled AD, despite aggressive traditional treatment.
Collapse
|
31
|
Abstract
Historically, osteopathic principles have focused on the appropriate drainage of cranial structures to relieve symptoms of rhinitis, which include nasal congestion, anterior/posterior rhinorrhea, sneezing, and itching. Allergic rhinitis is primarily an aberrant immunologic reaction caused by cytokines secreted from lymphocytes that traverse the lymphatic pathway throughout the body. Several studies have documented that, when manipulated, the lymphatic system enhanced the motion of these lymphocytes to important immune structures in both human and animal models. Additionally, modulation of both sympathetic and parasympathetic outflow has been found either to inhibit or enhance secretion and/or drainage of important allergic sites. Osteopathic approaches to rhinitis play an effective role in the comprehensive management of rhinitis, and techniques based on these approaches are therapeutic options for rhinitis. This article provides an up-to-date literature review about the management of rhinitis using the 5 models of osteopathic medicine: biomechanical, respiratory-circulatory, metabolic, neurologic, and behavioral.
Collapse
|
32
|
Kumar N, Graven K, Joseph NI, Johnson J, Fulton S, Hostoffer R, Abboud H. Case Report: Postvaccination Anti-Myelin Oligodendrocyte Glycoprotein Neuromyelitis Optica Spectrum Disorder: A Case Report and Literature Review of Postvaccination Demyelination. Int J MS Care 2020; 22:85-90. [PMID: 32410903 DOI: 10.7224/1537-2073.2018-104] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Stimulation of the immune response after vaccination can occasionally result in adverse effects, including demyelination of the central nervous system. The most common presentation of postvaccination demyelination is acute disseminated encephalomyelitis, but cases of optic neuritis, transverse myelitis, and multiple sclerosis relapses have been reported. More recently, an increasing number of postvaccination neuromyelitis optica spectrum disorder (NMOSD) cases have surfaced in the literature, especially in patients with aquaporin-4 antibodies. In this article, we report an unusual case of myelin oligodendrocyte glycoprotein antibody-related NMOSD after the receipt of multiple vaccines in a first-trimester pregnant woman from Africa. We review the reported cases of postvaccination demyelination in the past decade, with a focus on the relationship between NMOSD and vaccination in patients with aquaporin-4 or myelin oligodendrocyte glycoprotein antibodies. Finally, we discuss the clinical relevance of the present case and similar reported cases as it relates to patient care in the neuroimmunology clinic and identify potential areas for future research.
Collapse
|
33
|
Jeskey J, Parida A, Graven K, Hostoffer R. Specific Antibody Immunodeficiency Presenting With Streptococcal pneumonia-Induced Spontaneous Bacterial Peritonitis. ALLERGY & RHINOLOGY 2020; 11:2152656720928065. [PMID: 32537259 PMCID: PMC7268137 DOI: 10.1177/2152656720928065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Specific antibody immunodeficiency (SAD) is a primary immunodeficiency disorder characterized by normal levels of serum immunoglobulins (IgG, IgA, and IgM) associated with a dysfunctional immune response. SAD is associated with recurrent infections in the setting of an insufficient response to polysaccharide vaccinations. Streptococcus pneumoniae is a well-established cause of respiratory infections in SAD. However, there has been a paucity of evidence of pneumococcal peritonitis in SAD patients, being reported as spontaneous in acquired immunodeficiency such as AIDS. We report the first case of S. pneumoniae-induced peritonitis as the presenting sign for SAD.
Collapse
|
34
|
Rowane M, Valencia R, Stewart-Bates B, Casselman J, Hostoffer R. No Bull: A Case of Alpha-Gal Syndrome Associated With Buffalo Meat Sensitivity. ALLERGY & RHINOLOGY 2019; 10:2152656719893366. [PMID: 31840005 PMCID: PMC6902388 DOI: 10.1177/2152656719893366] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Introduction Alpha (⍺)-gal syndrome (AGS) is an immunoglobulin E (IgE) antibody response against the glycoprotein carbohydrate galactose-⍺-1,3-galactose-β-1-(3)4-N-acetylglucosamine-R (Gal⍺-1,3Galβ1-(3)4GlcNAc-R or ⍺-gal) that is present in Ixodida (tick) saliva and noncatarrhine mammals as well as cetuximab, antivenom, and the zoster vaccine. The most frequently observed anaphylactic reactions in AGS are observed after beef, pork, lamb, and deer meat consumption. We present the first case of anaphylaxis to buffalo meat. Case Report A 55-year-old man presented with a history of recurrent urticaria that only developed approximately 7 hours after buffalo consumption. The patient denied history of Ixodidae bites but admitted to frequent hiking outdoors. Anti-⍺-1,3-gal IgE was positive (30.80 kU/L). The patient was advised to strictly avoid red meat. Discussion The prevalence of AGS has been increased in all continents in the past decade, and several Ixodidae species have been associated with this hypersensitivity. The list of IgE-mediated reactions to various types of meat has expanded to kangaroo, whale, seal, and crocodile, although these have not been associated with AGS. van Nunen only cautioned against consumption of exotic meats, such as buffalo, but no published case report describes AGS associated with anaphylaxis to this type of meat. Conclusion AGS is a mammalian meat allergy that has been increasingly prevalent worldwide, especially in Ixodidae endemic regions of Australia and the United States. Multiple AGS case reports published in the past decade demonstrate rapidly increasing understanding of underlying mechanisms provoking ongoing sensitization to help devise management strategies and dietary information. We offer the first case report of delayed anaphylaxis to buffalo meat.
Collapse
|
35
|
Thoonkuzhy C, Shilian R, Hostoffer R. A case of cutaneous Mycobacterium chelonae in common variable immunodeficiency. Ann Allergy Asthma Immunol 2019; 124:210-211. [PMID: 31816394 DOI: 10.1016/j.anai.2019.11.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2019] [Revised: 11/19/2019] [Accepted: 11/25/2019] [Indexed: 10/25/2022]
|
36
|
Rowane M, Shilian R, Jhaveri DK, Tcheurekdjian HH, Sher TH, Hostoffer R. Familial Success in Allergen Desensitization. ALLERGY & RHINOLOGY 2019; 10:2152656719890315. [PMID: 31819808 PMCID: PMC6883665 DOI: 10.1177/2152656719890315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Introduction Allergic rhinitis (AR) is a widely prevalent immunoglobulin E-mediated
inflammatory nasal condition resulting from reexposure to an allergen in a
sensitized individual. The genetic associations behind AR and other allergic
conditions have been studied. However, familial success with AR therapies,
specifically allergen desensitization through subcutaneous immunotherapy
(SCIT), has never been reported in the literature. Pharmocogenetics has been
gradually applied to link heritable genetic variants with drug responses,
such as intergenic region variants APOBEC3B and APOBEC3C and β2-adrenergic
receptor and glycoprotein ADAM33 polymorphisms as predictive biomarkers for
biologic treatment response in asthma. We provide the first reported survey
of familial success with SCIT. Methods We administered a month-long, institutional review board-approved (20190493)
questionnaire to 200 adult patients receiving SCIT in a suburban
allergy/immunology practice. The anonymous survey inquired about
demographics, target allergens for their SCIT, current symptom improvement
on SCIT, and family history of allergies and SCIT management. Results Twenty-six percent (52 of 200, 26%) SCIT patients reported familial success
with the same allergy treatment modality. AR diagnosis and symptom
improvement from SCIT was similar among previous/same (18 of 52, 38%; 26 of
52, 54%) and subsequent (10 of 52, 21%; 19 of 52, 40%) generations of family
members. A combination of seasonal and perennial allergies was most
prevalent (81%) among this population. Conclusion In a subpopulation of SCIT patients, there appears to be a familial success
rate with this allergen desensitization treatment. This is the first
reported pharmocogenetic evidence of assessing hereditary influence on
effective AR therapy. Understanding pharmacogenetic associations involved
with SCIT may improve allergists’ recommendations for this treatment
option.
Collapse
|
37
|
Rowane M, Schend J, Patel J, Hostoffer R. Rapid desensitization of hydroxychloroquine. Ann Allergy Asthma Immunol 2019; 124:97-98. [PMID: 31606403 DOI: 10.1016/j.anai.2019.10.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2019] [Revised: 09/27/2019] [Accepted: 10/01/2019] [Indexed: 11/26/2022]
|
38
|
Horbal A, McGarry D, Reznick S, Hostoffer R, Tcheurekdjian H. Isolated parenchymal pulmonary presentation of familial Mediterranean fever. Ann Allergy Asthma Immunol 2019; 123:603-604. [PMID: 31494232 DOI: 10.1016/j.anai.2019.08.464] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2019] [Revised: 08/26/2019] [Accepted: 08/29/2019] [Indexed: 11/26/2022]
|
39
|
Sanan N, Lee J, Baxter C, Jeskey J, Hostoffer R. Delayed and protracted allergic reaction to oral lidocaine. Ann Allergy Asthma Immunol 2019; 123:413-414. [PMID: 30878625 DOI: 10.1016/j.anai.2019.03.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2018] [Revised: 02/19/2019] [Accepted: 03/06/2019] [Indexed: 11/19/2022]
|
40
|
Sanan N, Rowane M, Hostoffer R. Radiologic Contrast Media Desensitization for Delayed Cardiac Catheterization. ALLERGY & RHINOLOGY (PROVIDENCE, R.I.) 2019; 10:2152656719892844. [PMID: 31897351 PMCID: PMC6918493 DOI: 10.1177/2152656719892844] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
This protocol for rapid desensitization to intravenous radiographic contrast material (RCM) improves the strategy first reported by Uppal et al. Desensitization is a validated preventative measure for medical emergencies, such as cardiac catheterization, when patients present with histories of anaphylactoid reactions to the allergen of concern. The patient required another catheterization that was modified to repeat the final dosage of 320 mg/mL of Visipaque®, accommodating cardiac catheterization postponement, contrary to readministration of doses 4 (0.625 mg/mL) and 8 (10 mg/mL) as reported in Uppal et al. Our risk score calculations suggested that the patient was at low risk of contrast-induced nephropathy (CIN) that did not necessitate reduced dosage. No complications were reported following catheterization. We propose repetition of the final RCM dosage as a more effective and efficient desensitization strategy, as long as the scoring system does not indicate high risk for CIN.
Collapse
|
41
|
Schend J, McGarry D, Johnson J, Hostoffer R. Common variable immunodeficiency associated with stiff-person syndrome. Ann Allergy Asthma Immunol 2018; 120:444. [PMID: 29407421 DOI: 10.1016/j.anai.2018.01.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2017] [Revised: 12/30/2017] [Accepted: 01/03/2018] [Indexed: 12/29/2022]
|
42
|
Doll R, McGarry D, Jhaveri D, Hostoffer R, Tcheurekdjian H. HETEROZYGOUS MUTATIONS OF THE MAJOR HISTOCOMPATIBILITY CLASS-II ASSOCIATED MOLECULES. Ann Allergy Asthma Immunol 2018. [DOI: 10.1016/j.anai.2018.09.329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
43
|
Horbal A, McGarry D, Tcheurekdjian H, Hostoffer R, Reznick S. ATYPICAL PARENCHYMAL PULMONARY PRESENTATION OF STEROID-RESISTANT FAMILIAL MEDITERRANEAN FEVER TREATED WITH COLCHICINE. Ann Allergy Asthma Immunol 2018. [DOI: 10.1016/j.anai.2018.09.321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
44
|
Joseph N, Hostoffer R, Tcheurekdjian H. A NOVEL GENE MUTATION ASSOCIATED WITH COMMON VARIABLE IMMUNODEFICIENCY AND PYODERMA. Ann Allergy Asthma Immunol 2018. [DOI: 10.1016/j.anai.2018.09.308] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
45
|
Doll R, Friedman K, Hostoffer R. Aseptic Abscess Syndrome, a Case of Prolonged Remission Following Splenectomy. Am J Gastroenterol 2018; 113:1264-1265. [PMID: 29904157 DOI: 10.1038/s41395-018-0163-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/18/2017] [Accepted: 05/22/2018] [Indexed: 12/11/2022]
|
46
|
Oh J, McGarry DP, Joseph N, Peppers B, Hostoffer R. Salivary IgA deficiency in a patient with cystic fibrosis (genotype M470V/V520F). Ann Allergy Asthma Immunol 2018; 121:619-620. [PMID: 30392531 DOI: 10.1016/j.anai.2018.07.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2018] [Revised: 06/20/2018] [Accepted: 07/03/2018] [Indexed: 01/19/2023]
|
47
|
Peppers BP, Vatsayan A, Dalal J, Bonfield T, Tcheurekdjian H, Hostoffer R. A case series: Association of anaphylaxis with a significant decrease in platelet levels and possible secondary risk of thrombosis. IMMUNITY INFLAMMATION AND DISEASE 2018; 6:377-381. [PMID: 29701015 PMCID: PMC6113765 DOI: 10.1002/iid3.224] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/26/2017] [Revised: 03/08/2018] [Accepted: 04/05/2018] [Indexed: 11/24/2022]
Abstract
Introduction Anaphylaxis is a life threatening systemic inflammatory process that share mediators involved in the coagulation cascade. Platelet activating factor, known to increase platelet aggregation, has also been implicated as an important mediator of anaphylaxis. Although other inflammatory reactions are associated with an increased risk of thrombosis, anaphylaxis is currently not reported as one of them. Furthermore the role platelets may have in the perianaphylaxis period is not well understood. We here in present a retrospective case series of three patients that had platelet aberrations suggestive of PAF involvement and clinically significant thrombosis in close relationship with anaphylaxis. Objective To investigate platelet response before and after anaphylaxis and indirect observation evidence of platelet activating factors involvement with possible increased risk of thrombosis. Methods A retrospective investigation into medical records including medication administrations times, laboratory, and radiology results. Platelet levels pre‐ and post‐ anaphylaxis were statistically analyzed. Results Case 1, a 44 year old man had an anaphylactic reaction shortly after envenomation and subsequently suffered an acute infarction with thrombus in a cerebral artery. Case 2 is a 49 year old man with idiopathic anaphylaxis who developed a deep vein thrombosis after a protracted anaphylaxis event. Case 3 involved an 18 year old female with acute myeloid leukemia was found to have a thrombus in the celiac trunk following anaphylaxis. A paired two‐tailed Wilcoxon test on the subjects pre and post anaphylactic platelet levels resulted in a overall P < 0.0001. Conclusions and Clinical Relevance These three cases illustrate the potential role platelets may have in anaphylaxis and possible increased secondary risk for the development of thrombosis. Larger studies are required to determine incidence and risk factors for blood clots following anaphylaxis in order to provide management or screening recommendations.
Collapse
|
48
|
Schend J, Doll R, Sandhu M, Rodgers M, Hostoffer R. Mannose-binding lectin deficiency associated with numerous paraspinal neurofibromas. Ann Allergy Asthma Immunol 2017; 120:222-223. [PMID: 29162315 DOI: 10.1016/j.anai.2017.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2017] [Revised: 10/06/2017] [Accepted: 10/12/2017] [Indexed: 11/30/2022]
|
49
|
Johnson J, Abraham T, Sandhu M, Peppers B, Lyman B, Knorzer C, Romanello G, Tcheurekdjian H, Hostoffer R. OR003 Common misconceptions in the recognition and treatment of anaphylaxis in community hospital based medical professionals. Ann Allergy Asthma Immunol 2017. [DOI: 10.1016/j.anai.2017.08.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
50
|
Peppers B, Jhaveri D, Hostoffer R, Bonfield T. OR061 Stratification of peanut-murine model into anaphylaxis severity risk groups using intradermal testing read by thermography. Ann Allergy Asthma Immunol 2017. [DOI: 10.1016/j.anai.2017.08.049] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|